256.56

12.26% -35.86

Bio Rad Laboratories Inc (BIO)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Schlusskurs vom Vortag:

$292.42

Offen:

$251

24-Stunden-Volumen:

1.06M

Relative Volume:

5.09

Marktkapitalisierung:

$6.92B

Einnahmen:

$2.58B

Nettoeinkommen (Verlust:

$-778.69M

KGV:

-9.3875

EPS:

-27.33

Netto-Cashflow:

$223.75M

1W Leistung:

-14.91%

1M Leistung:

-20.37%

6M Leistung:

-10.66%

1J Leistung:

-16.26%

1-Tages-Spanne:

$251.00

$272.79

1-Wochen-Bereich:

$251.00

$301.47

52-Wochen-Spanne:

$211.43

$343.12

Bio Rad Laboratories Inc Stock (BIO) Company Profile

Firmenname

Bio Rad Laboratories Inc

Sektor

Healthcare (1111)

Branche

Medical Devices (139)

Telefon

(510) 724-7000

Adresse

1000 ALFRED NOBEL DRIVE, HERCULES

Mitarbeiter

7,700

Twitter

@BioRadLifeSci

Nächster Verdiensttermin

2024-10-30

Neueste SEC-Einreichungen

BIO's Discussions on Twitter

Compare BIO vs ABT, SYK, MDT, BSX, EW

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
BIO Bio Rad Laboratories Inc	256.56	7.89B	2.58B	-778.69M	223.75M	-27.33
ABT Abbott Laboratories	112.68	193.83B	44.33B	6.48B	6.92B	3.7033
SYK Stryker Corp	366.05	140.01B	25.12B	3.25B	4.28B	8.3984
MDT Medtronic Plc	99.49	129.33B	34.76B	4.79B	5.21B	3.7017
BSX Boston Scientific Corp	74.73	109.92B	20.08B	2.89B	3.82B	1.9391
EW Edwards Lifesciences Corp	75.87	44.36B	6.07B	1.06B	799.60M	1.8527

Bio Rad Laboratories Inc Stock (BIO) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2024-10-01	Hochstufung	Citigroup	Neutral → Buy
2024-08-28	Eingeleitet	Wells Fargo	Equal Weight
2024-06-03	Fortgesetzt	Jefferies	Hold
2024-04-03	Herabstufung	Citigroup	Buy → Neutral
2023-12-07	Eingeleitet	UBS	Buy
2023-06-16	Eingeleitet	Wells Fargo	Overweight
2022-12-07	Eingeleitet	RBC Capital Mkts	Outperform
2022-08-25	Eingeleitet	Credit Suisse	Outperform
2022-01-28	Bestätigt	Citigroup	Buy
2020-01-08	Eingeleitet	Wells Fargo	Overweight
2020-01-07	Eingeleitet	Citigroup	Buy
2018-10-17	Eingeleitet	Goldman	Buy
2018-09-20	Eingeleitet	Morgan Stanley	Equal-Weight
2018-02-16	Herabstufung	CL King	Buy → Neutral
2017-07-13	Eingeleitet	Wells Fargo	Outperform
2017-06-28	Hochstufung	Deutsche Bank	Hold → Buy
2017-01-18	Eingeleitet	Deutsche Bank	Hold
2016-10-13	Eingeleitet	CL King	Buy
2015-05-06	Bestätigt	Jefferies	Buy
2009-12-18	Eingeleitet	Maxim Group	Buy
2009-11-06	Eingeleitet	Jefferies & Co	Buy
2009-07-17	Eingeleitet	Soleil	Buy
2007-09-26	Eingeleitet	Banc of America Sec	Buy
2007-02-23	Herabstufung	Robert W. Baird	Outperform → Neutral

Alle ansehen

Bio Rad Laboratories Inc Aktie (BIO) Neueste Nachrichten

01:45 AM

Bio-Rad Laboratories (NYSE:BIO) Lowered to "Hold" Rating by Wall Street Zen - MarketBeat

01:45 AM

12:53 PM

Beyond the Balance Sheet: What SWOT Reveals About Bio-Rad Labora - GuruFocus

12:53 PM

Feb 13, 2026

Bio-Rad Q4 2025 slides reveal modest growth amid segment divergence and strategic shifts - Investing.com Nigeria

Feb 13, 2026

Bio-Rad Laboratories (NYSE:BIO.B) Shares Gap DownHere's What Happened - MarketBeat

Feb 13, 2026

Bio-Rad Laboratories (NYSE:BIO) Shares Gap Down After Earnings Miss - MarketBeat

Feb 13, 2026

Pinterest Posts Downbeat Results, Joins DraftKings, Toast, Expedia And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga

Feb 13, 2026

S&P 500 Futures Drop in Premarket Trading; Pinterest, Bio-Rad Labs A Lag - Barron's

Feb 13, 2026

12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga

Feb 13, 2026

BIO-RAD LABORATORIES, INC. SEC 10-K Report - TradingView

Feb 13, 2026

Bio-Rad (BIO) Reports Q4 Revenue Growth and Strategic Initiatives - GuruFocus

Feb 13, 2026